7 rezultatus
BACKGROUND
The improved survival of patients since the use of highly active antiretroviral treatments has lead to the reporting of non-AIDS defining tumors, such as lung cancer.
METHODS
Analysis of the records of 22 HIV-infected patients with lung cancer (LC) diagnosed in three hospitals located in
The purpose of this study was to determine the past-year prevalence estimates of cigarette smoking and eligibility for low-dose computed tomography (LDCT) lung cancer screening among older U.S. adults and examine potential variations in these estimates by sexual orientation. Data were from the
A counterimmunoelectrophoresis test for Pneumocystis carinii antigenemia was employed to assess the extent of subclinical infection or colonization with this agent in adults with infection, pulmonary disease, or malignancy and in healthy homosexual men. Antigenemia was detected in 6 of 208 (3%) of
The Italian Cooperative Group on AIDS-related tumors has collected 435 cases of HIV-associated tumors since December 1986. The following conclusions can be drawn from this IVDA-based series: (1) at least 15% of AIDS cases are associated with tumors; (2) the number of malignant lymphomas (high-grade
BACKGROUND
Lung cancer associated with acquired immunodeficiency syndrome (AIDS) is unusual. Literature review between 1984 and 1993 showed less than 100 published cases of this association. From those cases it appears that the neoplasia is more aggressive and survival after diagnosis is less than
A sensitive monoclonal antibody based ELISA was used to detect cell-free interleukin-2 receptor (IL-2R) in the body fluids of patients with acquired immune deficiency syndrome (AIDS), a variety of other disease conditions and a control group of apparently healthy (heterosexual and homosexual) males.
OBJECTIVE
To evaluate the cancer risk in southern European men with, or at risk of, HIV infection.
METHODS
An analysis of longitudinal data to assess time-dependent rare events.
METHODS
Data from a cohort of HIV seroconverters, and from two hospital-based HIV seroprevalent cohorts were combined and